WuXi AppTec: Net profit in the third quarter was 3.515 billion yuan, an increase of 53.27% year-on-year; net profit in the first three quarters was 12.076 billion yuan, an increase of 84.84% year-on-year. The main reason is that the company continued to focus on and strengthen the CRDMO business model, and the operating income continued to grow. At the same time, the company continued to optimize the production process and operating efficiency, as well as the production capacity efficiency broug...
药明康德:第三季度净利润35.15亿元,同比增长53.27%;前三季度净利润120.76亿元,同比增长84.84%。主要系公司持续聚焦及加强CRDMO业务模式,营业收入持续增长,同时持续优化生产工艺和经营效率,以及临床后期和商业化大项目增长带来的产能效率不断提升,提高了整体的盈利能力;同时,公司出售持有的联营企业WuXi XDC Cayman Inc.部分股票的收益,进一步提升了公司的利润。